EDGAR Filing Documents for 0001193125-13-199158

Form 8-K - Current report:

SEC Accession No. 0001193125-13-199158

Filing Date

2013-05-03

Accepted

2013-05-03 16:16:42

Documents

Period of Report

2013-04-29

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d531750d8k.htm	8-K	26829
2	EX-4.1	d531750dex41.htm	EX-4.1	60987
3	EX-10.1	d531750dex101.htm	EX-10.1	233881
4	EX-10.2	d531750dex102.htm	EX-10.2	163729
5	EX-99.1	d531750dex991.htm	EX-99.1	10109
6	GRAPHIC	g531750g10f08.jpg	GRAPHIC	4251
	Complete submission text file	0001193125-13-199158.txt		502863

Mailing Address 303B COLLEGE ROAD EAST PRINCETON NJ 08540

Business Address 303B COLLEGE ROAD EAST PRINCETON NJ 08540 (609) 243-0123

Celator Pharmaceuticals Inc (Filer) CIK: 0001327467 (see all company filings)